Immune complex removes receptors from stem cells to protect against cancer, preclinical study finds

by

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical study by Weill Cornell Medicine investigators.

Leave A Comment

Your email address will not be published. Required fields are marked *